According to a report by Fortune Business Insights, titled “Intracranial Stents Market Size, Share and Global Trend by Product (Self-Expanding Intracranial Stents, Embolization Coil Support Intracranial Stents), By Disease Indication (Brain Aneurysm, Intracranial Stenosis), By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others), and Geography Forecast till 2026,” the market derives growth from increasing regulatory approvals for related products.
Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/intracranial-stents-market-100396
Some of the major companies that are present in the Global Intracranial Stents Market are
- Acandis GmbH
- MicroPort Scientific India Pvt. Ltd.
- DePuy Synthes Companies
- Boston Scientific
- Penumbra, Inc. and BALT EXTRUSION
The use of intracranial stents in maintaining blood flow in the brain has led to a huge demand. The intracranial stent is implanted inside the brain of the person suffering from brain aneurysms and intracranial stenosis. Intracranial stents also help in reducing chances of stroke in patients with symptomatic intracranial stenosis.
According to the Brain Aneurysm Foundation, almost 6 million people in the United States are suffering from brain aneurysm. Furthermore, 30,000 people have undergone a brain rupture. Such high prevalence of brain aneurysm has led to the demand for intracranial stents. This, in turn will favor the growth of the global intracranial stents market in the forthcoming years.
Get Sample PDF Brochure at https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/intracranial-stents-market-100396
Stryker gets FDA Nod for Neuroform AtlasTM Stent System
The growing prevalence of aneurysm on a global scale has created the demand for more treatment methods. On account of the high prevalence, regulatory authorities have eased off their reluctance in approving newer treatment methods and drugs. The global intracranial stents market is likely to benefit from usage approvals. In 2017, Stryker received approval from the Food and Drug Administration for its Neuroform AtlasTM Stent System for marketing under Humanitarian Device Exemption (HDE). The device was used for treatment of wide neck intracranial aneurysms. The AtlasTM is designed to improve wall apposition and increase deployment accuracy even in the most difficult cases. The device will aid the treatment options for aneurysms and this in turn, is likely to favor the growth of the global intracranial stents market in the forthcoming years.
KEY QUESTIONS ANSWERED:
What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What Factors are estimated to drive and restrain the market growth?
What are the key technological and market trends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market share?
Why Choose Fortune Business Insights?
High Prevalence of Neurological Disorders is Creating High Demand
The high prevalence of neurological disorders has provoked several innovations in treatment options. According to the World Health Organization (WHO), between 1990 and 205, the number of deaths due to neurological disorders increased by 36.7%. The most commonly prevailing disorders were headache, Alzheimer’s disease and Dementias. Additionally, neurological disorders are major cause of disabilities worldwide. Such a high prevalence of neurological disorders will create a huge demand for devices for treatment of these disorders. Fortune Business Insights has predicted that the high prevalence of neurological disorders will have a positive impact on the global intracranial stents market in the coming years.
Fortune Business Insights has labelled increasing regulatory approvals as one of the leading factors that account for growth of the global intracranial stents market. Several companies have been encouraged by FDA’s recent trend of approval of related drugs and devices. Influenced by this factor companies have begun to shift their focus on the research and development of related products.
Segmentation for Intracranial Stents Market are;
- Self-Expanding Intracranial Stents
- Embolization Coil Support Intracranial Stents
By Disease Indication
- Brain Aneurysm
- Intracranial Stenosis
By End User
- Hospitals & Clinics
- Ambulatory Surgery Centers
More Trending Topics from Fortune Business Insights:
Pelvic Inflammatory Disease (PID) Treatment Market 2019 Global Industry Size, Share, Forecasts Analysis, Company Profiles, Competitive Landscape and Key Regions 2025
Hospital Architecture Market to Witness Astonishing Growth with HDR, HKS, Stantec, Jacobs Engineering Group and more